Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
CureVac NV Stock: Biotech Innovator Focused on mRNA Technology and Oncology Pipeline for Long-Term Investor Value
CureVac NV is a German biotech company specializing in mRNA technology for vaccines and therapeutics, with a particular focus on oncology and infectious diseases. The company’s business model leverages proprietary mRNA technology for rapid development and adaptability, supported by strategic partnerships and a broad pipeline. North American investors can access CureVac via Nasdaq under the ticker CVAC, with the company’s progress driven by pipeline catalysts, partnerships, and an oncology focus that presents significant market potential despite inherent biotech risks.